Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals. - Wikidata - wikimedia - TriplyDB

Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

http://www.wikidata.org/entity/Q35588145

about

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.Fatigue in HIV-Infected People: A Three-Year Observational Study.Fatigability as a function of physical activity energy expenditure in older adults.Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial.Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.Intensity, chronicity, circumstances, and consequences of HIV-related fatigue: a longitudinal study Thalamo-striato-cortical determinants to fatigue in multiple sclerosis Biomarkers for chronic fatigue.Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study.Fatigue in ankylosing spondylitis is associated with the brain networks of sensory salience and attention.

P2860

Q34466521-F73BE402-63C3-48A6-9CF0-D3DC06032708 Q35121171-EEC1B947-F510-42FA-9634-82AE94A6919B Q35822760-CFAC5160-1F05-4F56-98C4-8B47DA7E2B1A Q36528237-A0B12E0C-46AF-446E-BD1C-E5AF03E2CC65 Q36998562-797F932F-FE63-4D08-A7FD-17CE625132DD Q37064264-CD51D162-DDF6-49CA-833B-267A97C706DF Q37402245-6CC20A7A-7080-4B43-BE43-9AF9280A9245 Q37403706-2929E30D-CE8C-4570-9896-43A8D93986FB Q37730322-04420B82-07C5-4ECD-8384-EFBE05E356E1 Q39316540-D957445E-2F9C-4A43-9F67-32604F147DA2 Q44759133-E0EFA6F2-8C51-4B23-A4AA-EB170766BDA1

P2860

Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

http://www.wikidata.org/entity/Q35588145

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@ast

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@en

type

label

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@ast

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@en

prefLabel

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@ast

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@en

P1433

Q35588145-AC94B528-ED7E-48F6-9D26-739A24E3AFC8

P1476

Q35588145-5355C9F3-D276-4969-8C86-389EDD506CDA

P2093

Q35588145-2524AE12-F0DF-4846-ABDB-EE40F443048B

Q35588145-301CE484-9A0E-4574-AB77-CFB0822E3FD8

Q35588145-312AC935-D79C-41E4-8228-5324EC7F6CD2

Q35588145-358E18F5-2B2A-4F15-859F-BBBD23496690

Q35588145-58C28FCE-7066-4805-9DFF-2BCC5C2921E8

Q35588145-E3E4E807-5857-4E58-8896-0A9C851F325E

Q35588145-E54CE94A-6862-4C5C-81EC-70F0F18C2466

P2860

Q35588145-019751C7-3C7B-40D8-A484-4FAEEA99365B

Q35588145-12E71005-5DCC-48D6-A846-307D6DF40C62

Q35588145-14C76038-8364-40FF-ACC1-F78B0587200F

Q35588145-1659DC70-28A9-48BD-A56B-1FEAD6466642

Q35588145-1F88D11A-15DD-47E0-A0E8-0FB2679278F5

Q35588145-2E520E4F-AA2E-466B-A583-F5E31DD02788

Q35588145-3DC615EC-2D18-4464-A950-46C0FE6B8FC3

Q35588145-599FE38F-F535-43C4-AF7A-20626F75EF54

Q35588145-5FBFC1EE-A227-45F9-860F-596C0B7C0F6A

Q35588145-609035D2-0312-4626-B1B7-24B20836A8F0

P2888

Q35588145-1B338C3C-A395-4F68-A34C-3D7225C5D234

P304

Q35588145-40E52BB5-6EC7-4F44-9553-17B7EC677351

P31

Q35588145-C3C3B27F-30EB-4D60-B279-FD2E0DAD2600

P356

Q35588145-F8CDD151-D28B-4024-ABB7-903EBDF76DDA

P433

Q35588145-633E9BD1-3A84-4802-840F-6FC5DE177D84

P478

Q35588145-336081CF-5F1D-4089-B2E7-6C61E2ECC82F

P577

Q35588145-4C9FE4BE-6EEA-4248-A756-A61B6163B875

P5875

Q35588145-6547670C-DFFD-4A3C-B6CE-32F7B9507F94

P698

Q35588145-116F5720-9952-4E3B-8890-9E579B487135

P921

Q35588145-D5DD7D8F-D919-4E76-9174-0BB0CB79F4A6

P932

Q35588145-4E092F18-0711-4FE8-8F0C-DB1462DF6C41

P356

S13365-010-0010-5

P1433

Journal of NeuroVirology

P1476

Clinical, laboratory, and neur ...... e in HIV-infected individuals.

@en

P2093

David Clifford

http://www.w3.org/2001/XMLSchema#string

Giovanni Schifitto

http://www.w3.org/2001/XMLSchema#string

Jianhui Zhong

http://www.w3.org/2001/XMLSchema#string

Lijuan Deng

http://www.w3.org/2001/XMLSchema#string

Scott R Evans

http://www.w3.org/2001/XMLSchema#string

Thomas Ernst

http://www.w3.org/2001/XMLSchema#string

Tzu-Min Yeh

http://www.w3.org/2001/XMLSchema#string

P2860

Fatigue in levodopa-naive subjects with Parkinson disease.

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study.

Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.

Adverse effects of antiretroviral therapy.

Fatigue and basal ganglia.

Modafinil treatment for fatigue in HIV+ patients: a pilot study.

Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

Regulation of neural cell survival by HIV-1 infection.

P2888

s13365-010-0010-5

P304

17-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13365-010-0010-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49705412

http://www.w3.org/2001/XMLSchema#string

P698

21181521

http://www.w3.org/2001/XMLSchema#string

P921

P932

3229167

http://www.w3.org/2001/XMLSchema#string